Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugenia Vispo

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
AIDS Reviews|August 19, 2007
SPRING: a new trial to evaluate tipranavir in heterogeneous treatment-experienced HIV populationsEugenia Vispo
AIDS Reviews|April 25, 2008
Warning on hepatotoxicity of darunavirEugenia Vispo
AIDS Reviews|February 25, 2011
Prompt arrival of antivirals against hepatitis C for HIV patientsPablo Barreiro, Eugenia Vispo
AIDS (London, England)|April 14, 2011
New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis BVincent Soriano, Eugenia Vispo, Pablo Barreiro
Expert Opinion on Drug Metabolism & Toxicology|October 26, 2012
Pharmacokinetics of new oral hepatitis C antiviral drugsEugenia Vispo, Pablo Barreiro, Vicente Soriano
AIDS (London, England)|April 23, 2008
A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1Vincent Soriano, Eugenia Vispo, Pablo Labarga, et al.
Clinics in Liver Disease|August 3, 2013
Hepatitis B in HIV-infected patientsVincent Soriano, Eva Poveda, Eugenia Vispo, et al.
Expert Opinion on Pharmacotherapy|December 3, 2013
Emerging antiretroviral drugsJosé Vicente Fernández-Montero, Eugenia Vispo, Vicente Soriano
Enfermedades Infecciosas Y Microbiologia Clinica|February 7, 2009
[Role of tenofovir in HIV and hepatitis C virus coinfection]Paula Tuma, Eugenia Vispo, Pablo Barreiro, et al.
Seminars in Liver Disease|July 5, 2012
Management and treatment of chronic hepatitis C in HIV patientsPablo Barreiro, Eugenia Vispo, Pablo Labarga, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
AIDS Reviews|August 19, 2007
SPRING: a new trial to evaluate tipranavir in heterogeneous treatment-experienced HIV populationsEugenia Vispo
AIDS Reviews|April 25, 2008
Warning on hepatotoxicity of darunavirEugenia Vispo
AIDS Reviews|February 25, 2011
Prompt arrival of antivirals against hepatitis C for HIV patientsPablo Barreiro, Eugenia Vispo
AIDS (London, England)|April 14, 2011
New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis BVincent Soriano, Eugenia Vispo, Pablo Barreiro
Expert Opinion on Drug Metabolism & Toxicology|October 26, 2012
Pharmacokinetics of new oral hepatitis C antiviral drugsEugenia Vispo, Pablo Barreiro, Vicente Soriano
AIDS (London, England)|April 23, 2008
A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1Vincent Soriano, Eugenia Vispo, Pablo Labarga, et al.
Clinics in Liver Disease|August 3, 2013
Hepatitis B in HIV-infected patientsVincent Soriano, Eva Poveda, Eugenia Vispo, et al.
Expert Opinion on Pharmacotherapy|December 3, 2013
Emerging antiretroviral drugsJosé Vicente Fernández-Montero, Eugenia Vispo, Vicente Soriano
Enfermedades Infecciosas Y Microbiologia Clinica|February 7, 2009
[Role of tenofovir in HIV and hepatitis C virus coinfection]Paula Tuma, Eugenia Vispo, Pablo Barreiro, et al.
Seminars in Liver Disease|July 5, 2012
Management and treatment of chronic hepatitis C in HIV patientsPablo Barreiro, Eugenia Vispo, Pablo Labarga, et al.
Pageof 10